UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells

Journal of the American Chemical Society, 2018-02, Vol.140 (7), p.2478-2484

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

PLoS pathogens, 2017-12, Vol.13 (12), p.e1006740-e1006740

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Angewandte Chemie (International ed.), 2017-12, Vol.56 (50), p.16023-16027

International ed. in English, 2017

Link zum Volltext

Verfügbarkeit prüfen

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator

Viruses, 2021-01, Vol.13 (1), p.114

2021

Link zum Volltext

Verfügbarkeit prüfen

Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections

Viruses, 2024-04, Vol.16 (4), p.651

2024

Link zum Volltext

Verfügbarkeit prüfen

Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1262-1269

2013

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

Metabolism open, 2021-06, Vol.10, p.100090-100090, Article 100090

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2022-01, Vol.74 (1), p.95-104

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses

Antiviral research, 2006-09, Vol.71 (2), p.322-334

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers

Antimicrobial agents and chemotherapy, 2019-09, Vol.63 (9)

2019

Link zum Volltext

Verfügbarkeit prüfen

Lack of Pharmacokinetic Interaction between Amdoxovir and Reduced- and Standard-Dose Zidovudine in HIV-1-Infected Individuals

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1248-1255

2010

Link zum Volltext

Verfügbarkeit prüfen

Development of an Optimized Dose for Coformulation of Zidovudine with Drugs That Select for the K65R Mutation Using a Population Pharmacokinetic and Enzyme Kinetic Simulation Model

Antimicrobial Agents and Chemotherapy, 2008-12, Vol.52 (12), p.4241-4250

2008

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Angewandte Chemie International Edition, 2020-07, Vol.59 (31), p.12575-12575

International ed. in English, 2020

Link zum Volltext

Verfügbarkeit prüfen

Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Angewandte Chemie, 2017-12, Vol.129 (50), p.16239-16243

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model

Journal of neurovirology, 2020-12, Vol.26 (6), p.838-845

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study

Journal of clinical pharmacology, 2021-12, Vol.61 (12), p.1555-1566

2021

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous quantification of 9-(β- d-1,3-dioxolan-4-yl)guanine, Amdoxovir and Zidovudine in human plasma by liquid chromatography–tandem mass spectrometric assay

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-11, Vol.877 (29), p.3482-3488

2009

Link zum Volltext

Verfügbarkeit prüfen

Approaches to hepatitis C treatment and cure using NS5A inhibitors

Infection and drug resistance, 2014-01, Vol.7 (default), p.41-56

2014

Link zum Volltext

Verfügbarkeit prüfen

Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study

Cancer prevention research (Philadelphia, Pa.), 2014-03, Vol.7 (3), p.283-291

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of the Antiviral Agent β-d-2′-Deoxy-2′-Fluoro-2′-C-Methylcytidine in Rhesus Monkeys

Antimicrobial Agents and Chemotherapy, 2007-08, Vol.51 (8), p.2877-2882

2007

Link zum Volltext

Verfügbarkeit prüfen

Fluorescent Dye Terminator Sequencing Methods for Quantitative Determination of Replication Fitness of Human Immunodeficiency Virus Type 1 Containing the Codon 74 and 184 Mutations in Reverse Transcriptase

Journal of Clinical Microbiology, 2003-07, Vol.41 (7), p.3306-3311

2003

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Monocyte Efficacy Score Linked to Cognitive Impairment in Hiv

Antiviral therapy, 2012-01, Vol.17 (7), p.1233-1242

2012

Link zum Volltext

Verfügbarkeit prüfen

Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors

Current opinion in HIV & AIDS, 2013-11, Vol.8 (6), p.556

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(75)
Buchkapitel
(1)

Sprache

Englisch
(76)
Japanisch
(11)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(47)
Humans
(42)
Biological And Medical Sciences
(36)
Medical Sciences
(34)
Pharmacology. Drug Treatments
(28)
Antiviral Agents
(26)
Pharmacology & Pharmacy
(26)
Animals
(23)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(21)
Microbiology
(19)
Female
(16)
Infectious Diseases
(14)
Male
(14)
Macaca Mulatta
(11)
Pharmacokinetics
(11)
Antiviral Agents - Pharmacokinetics
(10)
Hiv
(10)
Adult
(9)
Human Immunodeficiency Virus 1
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator

Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections

Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses

Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers

Lack of Pharmacokinetic Interaction between Amdoxovir and Reduced- and Standard-Dose Zidovudine in HIV-1-Infected Individuals

Development of an Optimized Dose for Coformulation of Zidovudine with Drugs That Select for the K65R Mutation Using a Population Pharmacokinetic and Enzyme Kinetic Simulation Model

Corrigendum: Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model

Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study

Simultaneous quantification of 9-(β- d-1,3-dioxolan-4-yl)guanine, Amdoxovir and Zidovudine in human plasma by liquid chromatography–tandem mass spectrometric assay

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

Approaches to hepatitis C treatment and cure using NS5A inhibitors

Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study

Pharmacokinetics of the Antiviral Agent β-d-2′-Deoxy-2′-Fluoro-2′-C-Methylcytidine in Rhesus Monkeys

Fluorescent Dye Terminator Sequencing Methods for Quantitative Determination of Replication Fitness of Human Immunodeficiency Virus Type 1 Containing the Codon 74 and 184 Mutations in Reverse Transcriptase

Antiretroviral Monocyte Efficacy Score Linked to Cognitive Impairment in Hiv

Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors

Suchergebnisse filtern